RT Journal Article
SR Electronic
T1 Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.03.20121491
DO 10.1101/2020.06.03.20121491
A1 Zhaoyi Chen
A1 Hansi Zhang
A1 Yi Guo
A1 Thomas J George, Jr
A1 Mattia Prosperi
A1 William R. Hogan
A1 Zhe He
A1 Elizabeth A Shenkman
A1 Jiang Bian
YR 2020
UL http://medrxiv.org/content/early/2020/06/05/2020.06.03.20121491.abstract
AB Clinical trials are essential but often have high financial costs and long execution time. Trial simulation using real world data (RWD) could potentially provide insights on a treatment’s efficacy and safety before running a large-scale trial. In this work, we explored the feasibility of using RWD from a large clinical data research network to simulate a randomized controlled trial of Alzheimer’s disease considering two different scenarios: an one-arm simulation of the standard-of-care control arm; and a two-arm simulation comparing treatment safety between the intervention and control arms with proper patient matching algorithms. We followed original trial’s design and addressed some key questions, including how to translate trial criteria to database queries and establish measures of safety (i.e., serious adverse events) from RWD. Our simulation generated results comparable to the original trial, but also exposed gaps in both trial simulation methodology and the generalizability issue of clinical trials.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by NIH grants R21AG061431 and UL1TR001427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved as exempt by the University of Florida IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this work are available from the OneFlorida Clinical Research Consortium upon request and committee review.